Related references
Note: Only part of the references are listed.Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty
Alexander G. G. Turpie et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Cost-effectiveness of rivaroxaban versus enoxaparin for the prevention of postsurgical venous thromboembolism in Canada
Alexander Diamantopoulos et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement
B. I. Eriksson et al.
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME (2009)
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial
Alexander G. G. Turpie et al.
LANCET (2009)
A Cost-Effectiveness Model Comparing Rivaroxaban and Dabigatran Etexilate with Enoxaparin Sodium as Thromboprophylaxis after Total Hip and Total Knee Replacement in the Irish Healthcare Setting
Laura McCullagh et al.
PHARMACOECONOMICS (2009)
Prevention of venous thromboembolism
William H. Geerts et al.
CHEST (2008)
Physician compliance with guidelines for deep-vein thrombosis prevention in total hip and knee arthroplasty
Richard J. Friedman et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial
Ajay K. Kakkar et al.
LANCET (2008)
Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty
Bengt I. Eriksson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty
Michael R. Lassen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Cost-effectiveness of extended prophylaxis with fondaparinux compared with low molecular weight heparin against venous thromboembolism in patients undergoing hip fracture surgery
Jonas Lundkvist et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2007)
Effects of the oral, direct factor Xa inhibitor rivaroxaban on platelet-induced thrombin generation and prothrombinase activity
Jochen Graff et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: An administrative claims analysis from 30 managed care organizations
Alex C. Spyropoulos et al.
JOURNAL OF MANAGED CARE PHARMACY (2007)
Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgery
D. J. Quinlan et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Effectiveness of hip or knee replacement surgery in terms of quality-adjusted life years and costs
Pirjo Rasanen et al.
ACTA ORTHOPAEDICA (2007)
Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome
David A. MacDougall et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2006)
Cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against venous thromboembolism in patients undergoing hip fracture surgery
SD Sullivan et al.
VALUE IN HEALTH (2006)
Treatment patterns and real-world effectiveness of warfarin in nonvalvular atrial fibrillation within a managed care system
T Darkow et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis
SZ Goldhaber et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis
P Haentjens et al.
ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY (2004)
Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism
V Pengo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Measuring the outcomes and pharmacoeconomic consequences of venous thromboembolism prophylaxis in major orthopaedic surgery
SD Sullivan et al.
PHARMACOECONOMICS (2003)
Share Paper
